{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:26:54Z","timestamp":1772162814108,"version":"3.50.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Recent studies using laboratory clones have demonstrated that several antiretroviral protease inhibitors (PIs) inhibit the growth of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    at concentrations that may be of clinical significance, especially during human immunodeficiency virus type 1 (HIV-1) and malaria coinfection. Using clinical isolates, we now demonstrate the in vitro effectiveness of two HIV-1 aspartic PIs, saquinavir (SQV) and ritonavir (RTV), against\n                    <jats:italic>P. vivax<\/jats:italic>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    = 30) and\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    = 20) from populations subjected to high levels of mefloquine and artesunate pressure on the Thailand-Myanmar border. The median 50% inhibitory concentration values of\n                    <jats:italic>P. vivax<\/jats:italic>\n                    to RTV and SQV were 2,233 nM (range, 732 to 7,738 nM) and 4,230 nM (range, 1,326 to 8,452 nM), respectively, both within the therapeutic concentration range commonly found for patients treated with these PIs. RTV was fourfold more effective at inhibiting\n                    <jats:italic>P. vivax<\/jats:italic>\n                    than it was at inhibiting\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    , compared to a twofold difference in SQV sensitivity. An increased\n                    <jats:italic>P. falciparum mdr1<\/jats:italic>\n                    copy number was present in 33% (3\/9) of isolates and that of\n                    <jats:italic>P. vivax mdr1<\/jats:italic>\n                    was present in 9% of isolates (2\/22), but neither was associated with PI sensitivity. The inter-\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    sp. variations in PI sensitivity indicate key differences between\n                    <jats:italic>P. vivax<\/jats:italic>\n                    and\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    . PI-containing antiretroviral regimens may demonstrate prophylactic activity against both vivax and falciparum malaria in HIV-infected patients who reside in areas where multidrug-resistant\n                    <jats:italic>P. vivax<\/jats:italic>\n                    or\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    is found.\n                  <\/jats:p>","DOI":"10.1128\/aac.00169-08","type":"journal-article","created":{"date-parts":[[2008,4,28]],"date-time":"2008-04-28T20:53:45Z","timestamp":1209416025000},"page":"2435-2441","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Stronger Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against Clinical Isolates of\n                    <i>Plasmodium vivax<\/i>\n                    than against Those of\n                    <i>P. falciparum<\/i>"],"prefix":"10.1128","volume":"52","author":[{"given":"U.","family":"Lek-Uthai","sequence":"first","affiliation":[{"name":"Department of Parasitology, Faculty of Public Health, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Suwanarusk","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"},{"name":"Laboratory for Malaria Immunobiology, Singapore Immunology Network, Biopolis, Agency for Science Technology and Research (A*STAR), Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ruengweerayut","sequence":"additional","affiliation":[{"name":"Mae Sod Hospital, Tak, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. S.","family":"Skinner-Adams","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research and Australian Centre for International and Tropical Health and Nutrition, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nosten","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mae Sod, Thailand"},{"name":"Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"},{"name":"Faculty of Tropical Medicine, Mahidol University, Rajvithi Road, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research and Australian Centre for International and Tropical Health and Nutrition, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Boonma","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Public Health, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Piera","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. T.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research and Australian Centre for International and Tropical Health and Nutrition, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"MacHunter","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research and Australian Centre for International and Tropical Health and Nutrition, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M.","family":"Anstey","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Price","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"},{"name":"Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Russell","sequence":"additional","affiliation":[{"name":"International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia"},{"name":"Laboratory for Malaria Immunobiology, Singapore Immunology Network, Biopolis, Agency for Science Technology and Research (A*STAR), Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.76.641"},{"key":"e_1_3_2_3_2","first-page":"1791","volume":"315","year":"2007","unstructured":"Andrews, K. T., M. L. Gatton, T. S. Skinner-Adams, J. S. McCarthy, and D. L. Gardiner. 2007. HIV-malaria interactions: don't forget the drugs. Science315:1791.","journal-title":"Science"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4075-4083.2004"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.022630099"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.05768.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90080-4"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3201\/eid1302.060573","volume":"13","year":"2007","unstructured":"Brouwer, K. C., L. B. Mirel, C. Yang, R. B. Lal, M. S. Kolczak, A. M. Van Eijk, J. Ayisi, J. A. Otieno, B. L. Nahlen, R. Steketee, Y. P. Shi, and A. A. Lal. 2007. Subclinical Plasmodium falciparum infection and HIV-1 viral load. Emerg. Infect. Dis.13:351-353.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4922(01)02037-2"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(03)00137-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1468-1293.2003.00169.x","volume":"4","year":"2003","unstructured":"Dupuis, M. L., M. Flego, A. Molinari, and M. Cianfriglia. 2003. Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells. HIV Med.4:338-345.","journal-title":"HIV Med."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000069782","volume":"49","year":"2003","unstructured":"Dupuis, M. L., M. Tombesi, M. Sabatini, and M. Cianfriglia. 2003. Differential effect of HIV-1 protease inhibitors on P-glycoprotein function in multidrug-resistant variants of the human CD4+ T lymphoblastoid CEM cell line. Chemotherapy49:8-16.","journal-title":"Chemotherapy"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/med.20082","volume":"26","year":"2006","unstructured":"Ersmark, K., B. Samuelsson, and A. Hallberg. 2006. Plasmepsins as potential targets for new antimalarial therapy. Med. Res. Rev.26:626-666.","journal-title":"Med. Res. Rev."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/529192"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molbiopara.2004.01.010","volume":"135","year":"2004","unstructured":"Li, T., C. A. Yowell, B. B. Beyer, S. H. Hung, J. Westling, M. T. Lam, B. M. Dunn, and J. B. Dame. 2004. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man. Mol. Biochem. Parasitol.135:101-109.","journal-title":"Mol. Biochem. Parasitol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409740200"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.64.97"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80004-1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409605200"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.086272"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.7.2983-2985.2005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00022-06"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0035-9203(98)90750-7","volume":"92","year":"1998","unstructured":"Price, R., C. Luxemburger, M. van Vugt, F. Nosten, A. Kham, J. Simpson, S. Looareesuwan, T. Chongsuphajaisiddhi, and N. J. White. 1998. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria. Trans. R. Soc. Trop. Med. Hyg.92:207-211.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.12.2943"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.79"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16767-6"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1680-1685.2000"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328031f41a"},{"key":"e_1_3_2_29_2","first-page":"560","volume":"35","year":"2004","unstructured":"Rojanawatsirivet, C., K. Congpuong, S. Vijaykadga, S. Thongphua, K. Thongsri, K. N. Bangchang, P. Wilairatana, and W. H. Wernsdorfer. 2004. Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. Southeast Asian J. Trop. Med. Public Health35:560-565.","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01334-07"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.170-173.2003"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00840-06"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2008.03.008"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/425584"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QCO.0b013e328012c5cd","volume":"20","year":"2007","unstructured":"Slutsker, L., and B. J. Marston. 2007. HIV and malaria: interactions and implications. Curr. Opin. Infect. Dis.20:3-10.","journal-title":"Curr. Opin. Infect. Dis."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001089"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/509809"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-3156.1999.00349.x","volume":"4","year":"1999","unstructured":"Verhoeff, F. H., B. J. Brabin, C. A. Hart, L. Chimsuku, P. Kazembe, and R. L. Broadhead. 1999. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop. Med. Int. Health4:5-12.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3456-3462.2002"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00169-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00169-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:48:45Z","timestamp":1645454925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00169-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1128\/AAC.00169-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.00169-08","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13357037.14726326","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"2008-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-04-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}